Clinical Trial Update: Stem Cell Therapy for Intracerebral Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating mesenchymal stem cell therapy for intracerebral hemorrhage; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Tang Zhouping | Conditions: Intracerebral Hemorrhage, Mesenchymal Stem Cell | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING